On January 28, 2021, Establishment Labs Holdings Inc. announced David Hung resigned as a member of the Board of Directors of Establishment Labs Holdings Inc. and all committees of which he was a member. Dr. Hung’s resignation is effective February 11, 2021 and is a result of Dr. Hung limiting his public board work anticipating the public trading of Nuvation Bio Inc., of which he serves as Chief Executive Officer.